Cardiac 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with lewy bodies: Comparison with Alzheimer's disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 6, 2001, Pages 781-783

  Watanabe, H ^a   Ieda, T ^a   Katayama, T ^b   Takeda, A ^a   Aiba, I ^b   Doyu, M ^a   Hirayama, M ^a   Sobue, G ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Meito ku   (Japan)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Meta iodobenzylguanidine

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTONOMIC NERVE; CLINICAL ARTICLE; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; DRUG UPTAKE; FEMALE; HEART MUSCLE; HUMAN; LEWY BODY; MALE; NERVE DEGENERATION; NERVE INJURY; PRIORITY JOURNAL; REPRODUCIBILITY; SCINTIGRAPHY; SYMPATHETIC NERVE;

3-IODOBENZYLGUANIDINE; AGED; ALZHEIMER DISEASE; FEMALE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; MYOCARDIUM; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS;

EID: 0034987727     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.6.781     Document Type: Article

References (17)

1. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
2. Hansen LA. Dementia with Lewy bodies. In: Terry RD, Katzman R, eds. Alzheimer disease. 2nd ed. Philadelphia: Lippincott Williams and Wilkins, 1999:181-5.
3. Ince PG, Perry EK, Morris CM. Dementia with Lewy bodies: a distinct non-Alzheimer dementia syndrome. Brain Pathol 1998;8:299-324.
4. Kuzuhara S, Yoshimura M, Mizutani T, et al. Clinical features of diffuse Lewy body disease in the elderly: analysis of 12 cases. In: Perry RH, McKeith IG, Perry EK, eds. Dementia with Levy bodies. New York: Cambridge University Press, 1996:153-60.
5. Larner AJ, Mathias CJ, Rossor MN. Autonomic failure preceding dementia with Lewy bodies. J Neurol 2000;247: 229-31.
6. Kline RC, Swanson DP, Wieland DM, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nuck Med 1981;22:129-32.
7. 123I MIBG separates Parkinson's disease from multiple system atrophy. Neurology 1999;53:1020-5.
8. 123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder. Rinsho Shinkeigaku 1994;34:402-4.
9. 123I iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 1995;53:230-4.
10. 123I-mataiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67: 189-94.
11. 123I-iodobenzylguanidine in Parkinson's disease with autonomic failure. Acta Neurol Scand 1998;97: 307-14.
12. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
13. Takatsu H, Nishida H, Masuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000;41:71-7.
14. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body disease. Neurology 1999;52: 1269-71.
15. Bannister R, Mathias CJ. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. 4th ed. Oxford: Oxford University Press, 1999:534-44.
16. Ballard C, Shaw F, McKeith I, et al. High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 1998;51:1760-2.
17. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902-5.